Publications by authors named "Gordon Brandt"

Claim this Profile
A
A first-in-human study of BLZ-100 (tozuleristide) demonstrates tolerability and safety in skin cancer patients.
Miko Yamada, Dennis M Miller, Melinda Lowe, Casey Rowe, Dominic Wood, Gordon Brandt

Contemp Clin Trials Commun· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of sonothrombolysis for acute ischaemic stroke: a multicentre, double-blind, phase 3, randomised controlled trial.
Andrei V Alexandrov, Martin Köhrmann, Lauri Soinne, Georgios Tsivgoulis, Andrew D Barreto, Gordon Brandt

Lancet Neurol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined lysis of thrombus with ultrasound and systemic tissue plasminogen activator for emergent revascularization in acute ischemic stroke (CLOTBUST-ER): design and methodology of a multinational phase 3 trial.
Peter D Schellinger, Andrei V Alexandrov, Andrew D Barreto, Andrew M Demchuk, Georgios Tsivgoulis, Gordon Brandt

Int J Stroke· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of Calcitonin Salmon Nasal Spray: similarity of peptide formulated in chlorobutanol compared to benzalkonium chloride as preservative.
Henry R Costantino, Heather Culley, Lishan Chen, Daniel Morris, Michael Houston, Gordon Brandt

J Pharm Sci· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intranasal administration of acetylcholinesterase inhibitors.
Henry R Costantino, Alexis Kays Leonard, Gordon Brandt, Paul H Johnson, Steven C Quay

BMC Neurosci· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intranasal delivery: physicochemical and therapeutic aspects.
Henry R Costantino, Lisbeth Illum, Gordon Brandt, Paul H Johnson, Steven C Quay

Int J Pharm· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro formulation optimization of intranasal galantamine leading to enhanced bioavailability and reduced emetic response in vivo.
Alexis Kays Leonard, Anthony P Sileno, Gordon C Brandt, Charles A Foerder, Steven C Quay

Int J Pharm· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiosensitization of hypoxic tumor cells by dodecafluoropentane: a gas-phase perfluorochemical emulsion.
Cameron J Koch, Patricia R Oprysko, A Lee Shuman, W Timothy Jenkins, Gordon Brandt

Cancer Res· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis